PBL Assay Science
Private Company
Funding information not available
Overview
PBL Assay Science is a long-established, privately-held company operating in the research tools and services sector. It has built a reputation for providing high-quality, specialized reagents and assay services, particularly in cytokine detection and virology, which are essential for drug discovery and development workflows. The company's business model is based on product sales and fee-for-service contracts, generating revenue from a global customer base. While not a therapeutic developer itself, PBL is a key supplier to the life sciences ecosystem, with stability derived from its niche expertise and recurring demand for its research tools.
Technology Platform
Expertise in immunoassay development, protein/cytokine production, and virology assay services, centered on ELISA and neutralizing antibody assays.
Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded market dominated by giants like Bio-Techne (R&D Systems), Abcam, and Thermo Fisher. Competes on depth of expertise in specific areas like interferons/cytokines and custom assay services rather than breadth of catalog. Also faces competition from specialized CROs offering similar virology and immunology testing services.